2022³â °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç ¿¬¼ö±³À° : 2022-09-24±³À°ÀÏÀÚ : 2022-09-24
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç
±³À°ÁÖÁ¦ :
2022³â °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç ¿¬¼ö±³À°ÁÖÃÖ±â°ü : °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ
´ã´çÀÚ : ¹æöȯ
¿¬¶ôó : 02-2258-1395
À̸ÞÀÏ :
mrbangga@naver.com ±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 14:00~14:05 °³È¸»ç °ÈÆ(ÀºÆò¼º¸ðº´¿ø)
±³À°½Ã°£ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 14:05~14:35 Better Understanding Itch ±èÇý¼º(ÀÎõ¼º¸ðº´¿ø)
±³À°½Ã°£ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 14:35~14:55 New Classification and Treatment Outcome of Hand Vitiligo: A Cluster Analysis ÁÖÇöÁ¤(¼ººó¼¾Æ®º´¿ø)
±³À°½Ã°£ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 14:55~15:15 °Ç¼±¿¡¼ »ý¹°ÇÐÀû Á¦Á¦ »ç¿ë¿¡ µû¸¥ cardiovascular eventsÀÇ º¯È: National Cohort Study ¹æöȯ(¼¿ï¼º¸ðº´¿ø)
ÈÞ½Ä 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 15:15~15:35 Coffee Break ()
±³À°½Ã°£ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 15:35~15:55 ¸¸¼ºµÎµå·¯±â Ä¡·á °¡À̵å¶óÀÎ ¾÷µ¥ÀÌÆ®ÀÇ ÀÓ»óÀû Àû¿ë ÀÌÇöÁö(¿©Àǵµ¼º¸ðº´¿ø)
±³À°½Ã°£ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 15:55~16:15 Alopecia areata: An update on the pathogenesis and management ÀÌÁöÇý(¼ººó¼¾Æ®º´¿ø)
±³À°½Ã°£ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 16:15~16:35 Autophagy and skin disease ±èÇöÁö(ÀºÆò¼º¸ðº´¿ø)
ÈÞ½Ä 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 16:35~16:55 Coffee Break ()
±³À°½Ã°£ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 16:55~17:15 Recent advances in the understanding and management of rosacea ¿ìÀ¯¸®(ÀÎõ¼º¸ðº´¿ø)
±³À°½Ã°£ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 17:15~17:35 ÇÇºÎ¾Ï Ä¡·á¸¦ À§ÇÑ ±¤¹üÀ§ÀýÁ¦¼ú°ú ¸ðÁî¹Ì¼¼µµ½Ä ¼ö¼úÀÇ ºñ±³ ±è¿µÈ£(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 17:35~17:55 Overview of the immuno-pathophysiology of atopic dermatitis and emerging therapies ÃÖÁø¿µ(ÀÇÁ¤ºÎ¼º¸ðº´¿ø)
±âŸ 09-24 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 17:55~18:00 Æóȸ»ç °ÈÆ(ÀºÆò¼º¸ðº´¿ø)